Prenetics Global Limited (PRE) Stock Overview
Explore Prenetics Global Limited’s financial performance, market position, analyst ratings, and future outlook.
Prenetics Global Limited (PRE)
Key Financials
Key Financials
Market Cap
313.8M
P/E Ratio
-3.98
EPS (TTM)
$-2.06
ROE
-0.47%
PRE Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Prenetics Global Limited (NASDAQ: PRE) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Prenetics Global Limited's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of PRE on the NASDAQ shows an RSI of 46.12, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $23.08 for the NASDAQ listing.
Key metrics behind Prenetics Global Limited's NASDAQ-traded stock include a P/E ratio of -3.98 and a market capitalization of 313.8M. Combined with our AI analysis, these give both institutional and retail investors a clear view of PRE on the NASDAQ.